Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1868 1
1887 1
1913 1
1936 1
1938 1
1941 1
1942 1
1943 1
1946 1
1947 4
1948 5
1949 3
1950 3
1951 4
1952 3
1953 3
1954 1
1955 2
1956 3
1957 4
1959 3
1960 2
1961 2
1962 3
1963 1
1964 1
1967 2
1968 2
1969 2
1970 4
1971 2
1972 4
1973 3
1974 1
1975 4
1976 3
1977 2
1979 2
1980 3
1981 4
1982 2
1983 5
1984 4
1985 8
1986 10
1987 17
1988 15
1989 15
1990 12
1991 15
1992 18
1993 14
1994 18
1995 21
1996 12
1997 20
1998 16
1999 10
2000 18
2001 24
2002 7
2003 14
2004 26
2005 22
2006 25
2007 29
2008 17
2009 22
2010 32
2011 41
2012 33
2013 63
2014 61
2015 69
2016 37
2017 51
2018 61
2019 45
2020 78
2021 69
2022 55
2023 63
2024 42

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,225 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic criteria for nonviable pregnancy early in the first trimester.
Doubilet PM, Benson CB, Bourne T, Blaivas M; Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy; Barnhart KT, Benacerraf BR, Brown DL, Filly RA, Fox JC, Goldstein SR, Kendall JL, Lyons EA, Porter MB, Pretorius DH, Timor-Tritsch IE. Doubilet PM, et al. Among authors: benson cb. N Engl J Med. 2013 Oct 10;369(15):1443-51. doi: 10.1056/NEJMra1302417. N Engl J Med. 2013. PMID: 24106937 Review. No abstract available.
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
Gounder M, Ratan R, Alcindor T, Schöffski P, van der Graaf WT, Wilky BA, Riedel RF, Lim A, Smith LM, Moody S, Attia S, Chawla S, D'Amato G, Federman N, Merriam P, Van Tine BA, Vincenzi B, Benson C, Bui NQ, Chugh R, Tinoco G, Charlson J, Dileo P, Hartner L, Lapeire L, Mazzeo F, Palmerini E, Reichardt P, Stacchiotti S, Bailey HH, Burgess MA, Cote GM, Davis LE, Deshpande H, Gelderblom H, Grignani G, Loggers E, Philip T, Pressey JG, Kummar S, Kasper B. Gounder M, et al. Among authors: benson c. N Engl J Med. 2023 Mar 9;388(10):898-912. doi: 10.1056/NEJMoa2210140. N Engl J Med. 2023. PMID: 36884323 Free PMC article. Clinical Trial.
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.
Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, Lehmann C, Springer SA, Sax PE, Thompson MA, Benson CA, Buchbinder SP, Del Rio C, Eron JJ Jr, Günthard HF, Molina JM, Jacobsen DM, Saag MS. Gandhi RT, et al. Among authors: benson ca. JAMA. 2023 Jan 3;329(1):63-84. doi: 10.1001/jama.2022.22246. JAMA. 2023. PMID: 36454551
Editorial Comment.
Benson CR. Benson CR. J Urol. 2023 Dec;210(6):873. doi: 10.1097/JU.0000000000003693.03. Epub 2023 Dec 1. J Urol. 2023. PMID: 37942858 No abstract available.
Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes.
Pratt E, Ma X, Liu R, Robins D, Coskun T, Sloop KW, Haupt A, Benson C. Pratt E, et al. Among authors: benson c. Diabetes Obes Metab. 2023 Sep;25(9):2642-2649. doi: 10.1111/dom.15150. Epub 2023 Jun 1. Diabetes Obes Metab. 2023. PMID: 37264711 Clinical Trial.
Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study in healthy participants.
Pratt E, Ma X, Liu R, Robins D, Haupt A, Coskun T, Sloop KW, Benson C. Pratt E, et al. Among authors: benson c. Diabetes Obes Metab. 2023 Sep;25(9):2634-2641. doi: 10.1111/dom.15184. Epub 2023 Jun 21. Diabetes Obes Metab. 2023. PMID: 37344954 Clinical Trial.
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
Swindells S, Ramchandani R, Gupta A, Benson CA, Leon-Cruz J, Mwelase N, Jean Juste MA, Lama JR, Valencia J, Omoz-Oarhe A, Supparatpinyo K, Masheto G, Mohapi L, da Silva Escada RO, Mawlana S, Banda P, Severe P, Hakim J, Kanyama C, Langat D, Moran L, Andersen J, Fletcher CV, Nuermberger E, Chaisson RE; BRIEF TB/A5279 Study Team. Swindells S, et al. Among authors: benson ca. N Engl J Med. 2019 Mar 14;380(11):1001-1011. doi: 10.1056/NEJMoa1806808. N Engl J Med. 2019. PMID: 30865794 Free PMC article. Clinical Trial.
Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement.
Levine D, Brown DL, Andreotti RF, Benacerraf B, Benson CB, Brewster WR, Coleman B, Depriest P, Doubilet PM, Goldstein SR, Hamper UM, Hecht JL, Horrow M, Hur HC, Marnach M, Patel MD, Platt LD, Puscheck E, Smith-Bindman R. Levine D, et al. Among authors: benson cb. Radiology. 2010 Sep;256(3):943-54. doi: 10.1148/radiol.10100213. Epub 2010 May 26. Radiology. 2010. PMID: 20505067 Free PMC article. Review.
AUTHOR REPLY.
Benson CR, Raheem O. Benson CR, et al. Urology. 2021 Jan;147:293. doi: 10.1016/j.urology.2020.07.092. Urology. 2021. PMID: 33390210 No abstract available.
1,225 results